Wilson Sonsini Goodrich & Rosati advised Chroma Medicine on the deal.Chroma Medicine, a new genomic medicine company pioneering epigenetic editing, launched with $125 million in financing….
This content is for Standard 1 Year members only. LoginJoin Now
Author: Martina Bellini
…
This content is for Standard 1 Year members only. LoginJoin Now